SCHEMBL29861393

SCHEMBL29861393

CN[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)OC(C)(C)C

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 1/20 0.56
MMP3 P08254 1/20 0.56
MMP9 P14780 1/20 0.56
TDP1 Q9NUW8 4/20 0.55
MAPT P10636 6/20 0.55
POLB P06746 3/20 0.55
ALDH1A1 P00352 2/20 0.54
THRB P10828 1/20 0.54
CYP2C9 P11712 1/20 0.54
CYP2C19 P33261 1/20 0.54
HSD17B10 Q99714 1/20 0.54
ITGA4 P13612 1/20 0.53
ITGB7 P26010 1/20 0.53
CTSS P25774 2/20 0.52
CTSL P07711 1/20 0.52
CTSB P07858 1/20 0.52
CTSK P43235 1/20 0.52
NPSR1 Q6W5P4 3/20 0.52
ATM Q13315 1/20 0.52
RECQL P46063 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13020625 1.00 MMP1 (0.56) MMP1MMP3MMP9TDP1MAPT
SCHEMBL31293782 0.90 MMP1 (0.58) MMP1MMP3MMP9TDP1MAPT
SCHEMBL30065139 0.89 CTSS (0.60) MMP1MMP3MMP9TDP1MAPT
SCHEMBL15223643 0.87 ALDH1A1 (0.64) MMP1MMP3MMP9TDP1MAPT
SCHEMBL29861037 0.86 POLB (0.59) MMP1MMP3MMP9TDP1MAPT
SCHEMBL25680509 0.86 MMP1 (0.49) MMP1MMP3MMP9TDP1CTSS
SCHEMBL1437012 0.86 MMP1 (0.57) MMP1MMP3MMP9TDP1MAPT
SCHEMBL1509254 0.85 CTSK (0.57) MMP1MMP3MMP9CTSSCTSL
SCHEMBL19945249 0.85 ITGA4 (0.61) MMP1MMP3MMP9TDP1MAPT
SCHEMBL19945248 0.85 ITGA4 (0.61) MMP1MMP3MMP9TDP1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4685150-A1 METHOD FOR PRODUCING AMIDE GROUP-CONTAINING COMPOUND USING N-CARBOXYAMINO ACID ANHYDRIDE CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2026-01-28 EP disclosed
WO-2024225377-A1 METHOD FOR PRODUCING AMIDE GROUP-CONTAINING COMPOUND USING N-CARBOXYAMINO ACID ANHYDRIDE 中外製薬株式会社 2024-10-31 WO disclosed
US-20230056969-A1 METHOD FOR SYNTHESIZING PEPTIDE COMPOUND CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2023-02-23 US disclosed
EP-4083051-A1 METHOD FOR SYNTHESIZING PEPTIDE COMPOUND CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2022-11-02 EP disclosed
CN-114867734-A Method for synthesizing peptide compound 中外制药株式会社 2022-08-05 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230056969-A1 METHOD FOR SYNTHESIZING PEPTIDE COMPOUND VIP, NGLY1, NPPA MMP1 2229/4885MMP3 2231/4885MMP9 2700/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.